376 research outputs found
The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries
BACKGROUND: Coronavirus disease 2019 (COVID-19) has associated cutaneous manifestations.
OBJECTIVE: To characterize the diversity of cutaneous manifestations of COVID-19, and facilitate understanding of underlying pathophysiology.
METHODS: Case series from an international registry from the American Academy of Dermatology and International League of Dermatological Societies.
RESULTS: The registry collected 716 cases of new-onset dermatologic symptoms in patients with confirmed/suspected COVID-19. Of the 171 patients in the registry with laboratory-confirmed COVID-19, the most common morphologies were morbilliform (22%), pernio-like (18%), urticarial (16%), macular erythema (13%), vesicular (11%), papulosquamous (9.9%), and retiform purpura (6.4%). Pernio-like lesions were common in patients with mild disease, while retiform purpura presented exclusively in ill, hospitalized patients.
LIMITATIONS: We cannot estimate incidence or prevalence. Confirmation bias is possible.
CONCLUSION: This study highlights the array of cutaneous manifestations associated with COVID-19. Many morphologies were non-specific, while others may provide insight into potential immune or inflammatory pathways in COVID-19 pathophysiology
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
BACKGROUND: Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines have been reported but are not well characterized.
OBJECTIVE: To evaluate the morphology and timing of cutaneous reactions after mRNA COVID-19 vaccines.
METHODS: A provider-facing registry-based study collected cases of cutaneous manifestations after COVID-19 vaccination.
RESULTS: From December 2020 to February 2021, we recorded 414 cutaneous reactions to mRNA COVID-19 vaccines from Moderna (83%) and Pfizer (17%). Delayed large local reactions were most common, followed by local injection site reactions, urticarial eruptions, and morbilliform eruptions. Forty-three percent of patients with first-dose reactions experienced second-dose recurrence. Additional less common reactions included pernio/chilblains, cosmetic filler reactions, zoster, herpes simplex flares, and pityriasis rosea-like reactions.
LIMITATIONS: Registry analysis does not measure incidence. Morphologic misclassification is possible.
CONCLUSIONS: We report a spectrum of cutaneous reactions after mRNA COVID-19 vaccines. We observed some dermatologic reactions to Moderna and Pfizer vaccines that mimicked SARS-CoV-2 infection itself, such as pernio/chilblains. Most patients with first-dose reactions did not have a second-dose reaction and serious adverse events did not develop in any of the patients in the registry after the first or second dose. Our data support that cutaneous reactions to COVID-19 vaccination are generally minor and self-limited, and should not discourage vaccination
Recommended from our members
Comparison of herbarium label data and published medicinal use: herbaria as an underutilized source of ethnobotanical information
The use of herbarium specimens as vouchers to support ethnobotanical surveys is well established. However,
herbaria may be underutilized resources for ethnobotanical research that depends on the analysis of large datasets compiled across multiple sites. Here, we compare two medicinal use datasets, one sourced from
published papers and the other from online herbaria to determine whether herbarium and published data
are comparable and to what extent herbarium specimens add new data and fill gaps in our knowledge of
geographical extent of plant use. Using Brazilian legumes as a case study, we compiled 1400 use reports from
105 publications and 15 Brazilian herbaria. Of the 319 species in 107 genera with cited medicinal uses, 165
(51%) were recorded only in the literature and 55 (17%) only on herbarium labels. Mode of application,
plant part used, or therapeutic use was less often documented by herbarium specimen labels (17% with
information) than publications (70%). However, medicinal use of 21 of the 128 species known from only
one report in the literature was substantiated from independently collected herbarium specimens, and 58
new therapeutic applications, 25 new plant parts, and 16 new modes of application were added for species
known from the literature. Thus, when literature reports are few or information-poor, herbarium data can
both validate and augment these reports. Herbarium data can also provide insights into the history and
geographical extent of use that are not captured in publications
The Extended Specimen Network: A Strategy to Enhance US Biodiversity Collections, Promote Research and Education
Biogeographical analyses to facilitate targeted conservation of orchid diversity hotspots in Costa Rica
Aim: We conduct a biogeographical assessment of orchids in a global biodiversity
hotspot to explore their distribution and occurrences of local hotspots while identifying geographic attributes underpinning diversity patterns. We evaluate habitat
characteristics associated with orchid diversity hotspots and make comparisons to
other centres of orchid diversity to test for global trends. The ultimate goal was to
identify an overall set of parameters that effectively characterize critical habitats to
target in local and global orchid conservation efforts.
Location: Costa Rica; Mesoamerica.
Taxon: Orchidaceae.
Methods: Data from an extensive set of herbarium records were used to map orchid
distributions and to identify diversity hotspots. Hotspot data were combined with
geographic attribute data, including environmental and geopolitical variables, and a
random forest regression model was utilized to assess the importance of each variable for explaining the distribution of orchid hotspots. A likelihood model was created based on variable importance to identify locations where suitable habitats and
unidentified orchid hotspots might occur.
Results: Orchids were widely distributed and hotspots occurred primarily in mountainous regions, but occasionally at lower elevations. Precipitation and vegetation
cover were the most important predictive variables associated with orchid hotspots.
Variable values underpinning Costa Rican orchid hotspots were similar to those reported at other sites worldwide. Models also identified suitable habitats for sustaining orchid diversity that occurred outside of known hotspots and protected areas.
Main conclusions: Several orchid diversity hotspots and potentially suitable habitats
occur outside of known distributions and/or protected areas. Recognition of these
sites and their associated geographic attributes provides clear targets for optimizing
orchid conservation efforts in Costa Rica, although certain caveats warrant consideration. Habitats linked with orchid hotspots in Costa Rica were similar to those documented elsewhere, suggesting the existence of a common biogeographical trend
regarding critical habitats for orchid conservation in disparate tropical regions.Universidad de Puerto Rico/[]/UPR/Puerto RicoUniversidad de Costa Rica/[]/UCR/Costa RicaUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Agroalimentarias::Jardín Botánico Lankester (JBL
Morphology of seeds and seedlings of four species of Vigna Savi (Leguminosae, Phaseolinae)
Standardizing Clinical Trials Workflow Representation in UML for International Site Comparison
BACKGROUND: With the globalization of clinical trials, a growing emphasis has been placed on the standardization of the workflow in order to ensure the reproducibility and reliability of the overall trial. Despite the importance of workflow evaluation, to our knowledge no previous studies have attempted to adapt existing modeling languages to standardize the representation of clinical trials. Unified Modeling Language (UML) is a computational language that can be used to model operational workflow, and a UML profile can be developed to standardize UML models within a given domain. This paper's objective is to develop a UML profile to extend the UML Activity Diagram schema into the clinical trials domain, defining a standard representation for clinical trial workflow diagrams in UML. METHODS: Two Brazilian clinical trial sites in rheumatology and oncology were examined to model their workflow and collect time-motion data. UML modeling was conducted in Eclipse, and a UML profile was developed to incorporate information used in discrete event simulation software. RESULTS: Ethnographic observation revealed bottlenecks in workflow: these included tasks requiring full commitment of CRCs, transferring notes from paper to computers, deviations from standard operating procedures, and conflicts between different IT systems. Time-motion analysis revealed that nurses' activities took up the most time in the workflow and contained a high frequency of shorter duration activities. Administrative assistants performed more activities near the beginning and end of the workflow. Overall, clinical trial tasks had a greater frequency than clinic routines or other general activities. CONCLUSIONS: This paper describes a method for modeling clinical trial workflow in UML and standardizing these workflow diagrams through a UML profile. In the increasingly global environment of clinical trials, the standardization of workflow modeling is a necessary precursor to conducting a comparative analysis of international clinical trials workflows
Lichenological exploration of Algeria: historical overview and annotated bibliography, 1799-2013
yesDespite more than two centuries of almost uninterrupted surveys and studies of Algerian lichenology, the history and lichen diversity of Algeria are still poorly understood. During the preparation of a forthcoming checklist of Algerian lichens it was considered necessary to provide the present historical overview of lichenological exploration of the country from 1799 to 2013, supported by a reasonably comprehensive annotated bibliography of 171 titles
Fabaceae of the Rio São Francisco River sub-basin, Nova Marilândia, Mato Grosso, Brazil
Taxonomic studies of Amanita muscaria (L.) Lam (Amanitaceae, Agaricomycetes) and its infraspecific taxa in Brazil
- …